Alphatec (NASDAQ:ATEC – Free Report) had its price objective lifted by Needham & Company LLC from $19.00 to $22.00 in a research report report published on Wednesday, Benzinga reports. Needham & Company LLC currently has a buy rating on the medical technology company’s stock. Several other research analysts have also weighed in on the company. […]